Wockhardt Gains 3% On USFDA Approval For Cancer Drug

Wockhardt Gains 3% On USFDA Approval For Cancer Drug

Thursday, April 11, 2019
Wockhardt will be launching this product in the UnitedStates, in a short period of time.

Share price of Wockhardt added 3.5 percent in the early trade on Thursday after it received USFDA approval for cancer drug.

For more information on Indian Share Market Tips For Tomorrow

and quick free trial click here > 911 133 9000

Visit http://www.epicresearch.co

Connect with our social media sites
Next
« Prev Post
Previous
Next Post »